Clinical Trials Browser

Phase 4 × pyrotinib × 90 days × Clear all

NCT07600164 2026-05-20

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms